Kyle Steiger
Corporate Officer/Principal at VALEO PHARMA INC.
Net worth: 2 424 $ as of 2024-03-30
Profile
Kyle Steiger is a professional who currently holds the position of Chief Commercial Officer & Senior Vice President at Valeo Pharma, Inc. Prior to this, he worked as VP-Ophthalmology, Primary Care & Franchise at Novartis Pharmaceuticals Canada, Inc. and as Vice President-Commercial Services at Ashfield Healthcare Canada, Inc. He completed his undergraduate degree at Brock University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VALEO PHARMA INC CLASS A
0.02% | 2023-11-28 | 19,394 ( 0.02% ) | 2 424 $ | 2024-03-30 |
Kyle Steiger active positions
| Companies | Position | Start |
|---|---|---|
| VALEO PHARMA INC. | Corporate Officer/Principal | 2022-08-29 |
Former positions of Kyle Steiger
| Companies | Position | End |
|---|---|---|
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Corporate Officer/Principal | - |
| Ashfield Healthcare Canada, Inc. | Corporate Officer/Principal | - |
Training of Kyle Steiger
| Brock University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Health Technology |
| Valeo Pharma, Inc. | |
| Ashfield Healthcare Canada, Inc. |
- Stock Market
- Insiders
- Kyle Steiger